JT Stratford LLC Sells 5,064 Shares of Cigna Group $CI

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

JT Stratford LLC reduced its holdings in Cigna Group (NYSE:CI - Free Report) by 40.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,532 shares of the health services provider's stock after selling 5,064 shares during the quarter. JT Stratford LLC's holdings in Cigna Group were worth $2,478,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in CI. T. Rowe Price Investment Management Inc. bought a new stake in shares of Cigna Group in the 4th quarter worth approximately $724,517,000. Nuveen LLC acquired a new stake in shares of Cigna Group during the first quarter valued at approximately $727,905,000. GAMMA Investing LLC raised its holdings in shares of Cigna Group by 58,799.0% during the first quarter. GAMMA Investing LLC now owns 1,774,626 shares of the health services provider's stock valued at $583,852,000 after acquiring an additional 1,771,613 shares during the period. GQG Partners LLC raised its holdings in shares of Cigna Group by 21.5% during the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider's stock valued at $1,607,716,000 after acquiring an additional 865,092 shares during the period. Finally, Two Sigma Advisers LP raised its holdings in shares of Cigna Group by 278.0% during the fourth quarter. Two Sigma Advisers LP now owns 816,200 shares of the health services provider's stock valued at $225,385,000 after acquiring an additional 600,300 shares during the period. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Stock Up 1.1%

Cigna Group stock traded up $3.1890 during trading hours on Friday, hitting $304.1390. The company had a trading volume of 1,127,473 shares, compared to its average volume of 1,847,744. The firm has a market capitalization of $81.18 billion, a P/E ratio of 16.60, a price-to-earnings-growth ratio of 0.89 and a beta of 0.47. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm's fifty day moving average is $301.16 and its 200-day moving average is $311.31. Cigna Group has a fifty-two week low of $256.89 and a fifty-two week high of $370.83.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating the consensus estimate of $7.15 by $0.05. The firm had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company's revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th will be given a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Thursday, September 4th. Cigna Group's payout ratio is currently 32.97%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on CI shares. Morgan Stanley boosted their price target on shares of Cigna Group from $379.00 to $390.00 and gave the company an "overweight" rating in a report on Monday, May 5th. Wall Street Zen lowered shares of Cigna Group from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Cowen restated a "buy" rating on shares of Cigna Group in a report on Monday, May 5th. TD Cowen upgraded shares of Cigna Group to a "strong-buy" rating in a report on Monday, June 23rd. Finally, Robert W. Baird set a $372.00 price target on shares of Cigna Group in a report on Thursday, August 14th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $374.82.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the business's stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares of the company's stock, valued at $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.70% of the stock is owned by corporate insiders.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.